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Abstract
Background: The trapezius muscle is a neck muscle that is susceptible to chronic pain conditions associated with
repetitive tasks, commonly referred to as chronic work-related myalgia, hence making the trapezius a muscle of
clinical interest. To provide a basis for further investigations of the proteomic traits of the trapezius muscle in
disease, two-dimensional difference gel electrophoresis (2D-DIGE) was performed on the healthy trapezius using
vastus lateralis as a reference. To obtain as much information as possible from the vast proteomic data set, both
one-way ANOVA, with and without false discovery rate (FDR) correlation, and partial least square projection to
latent structures with discriminant analysis (PLS-DA) were combined to compare the outcome of the analysis.
Results: The trapezius and vastus lateralis showed significant differences in metabolic, contractile and regulatory
proteins, with different results depending on choice of statistical approach and pre-processing technique. Using
the standard method, FDR correlated one-way ANOVA, 42 protein spots differed significantly in abundance
between the two muscles. Complementary analysis using immunohistochemistry and western blot confirmed the
results from the 2D-DIGE analysis.
Conclusions: The proteomic approach used in the present study combining 2D-DIGE and multivariate modelling
provided a more comprehensive comparison of the protein profiles of the human trapezius and vastus lateralis
muscle, than previously possible to obtain with immunohistochemistry or SDS-PAGE alone. Although 2D-DIGE has
inherent limitations it is particularly useful to comprehensively screen for important structural and metabolic
proteins, and appears to be a promising tool for future studies of patients suffering from chronic work related
myalgia or other muscle diseases.
Background
The trapezius muscle is a common location for chronic
work-related musculoskeletal disorders [1], a condition
often referred to as trapezius myalgia [2]. Several models
regarding the pathophysiology behind trapezius myalgia
have been proposed and were reviewed by Visser &
Vaan Dieen [3]. Although the exact mechanisms are
unclear, a difference in metabolism between healthy and
myalgic muscle has been observed [3]. However, differ-
ences in metabolism may reflect the differences in fiber
type composition [4-6]. Several studies investigating
fiber type composition of myalgic trapezius muscle in
comparison to healthy muscle show hypertrophy [7,8] of
the slow twitch type 1 fibers. A thorough histochemical
characterisation of fiber type composition in ascending,
transverse and descending portions of the healthy trape-
zius muscle was previously presented [9,10]. The most
well studied portion of the trapezius muscle is the des-
cending part, which is frequently subjected to loading
during shoulder and upper extremity movements [11].
The possible significance of the specific features of the
trapezius muscle can be appreciated by comparison to
other muscles that are not susceptible to work related
muscle pain. The vastus lateralis is a reference muscle
of choice because it is a well studied human muscle,
routinely used for diagnostic muscle biopsies; and is not
a subject to work related myalgia. The vastus lateralis
muscle has approximately 50% type 1 fibers [12,13],
* Correspondence: jhi@hig.se
1Department of Integrative Medical Biology, Anatomy, Umeå University, S-
901 87 Umeå, Sweden
Full list of author information is available at the end of the article
Hadrévi et al. BMC Musculoskeletal Disorders 2011, 12:181
http://www.biomedcentral.com/1471-2474/12/181
© 2011 Hadrévi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.whereas the descending part of the trapezius muscle has
a predominance of type 1 fibers, i.e. approximately 65%
[4,9]. The trapezius and vastus lateralis muscles also dif-
fers in capillary supply [14,15] and androgen receptor
content [16]. A broader analysis of the protein composi-
tion of the trapezius muscle can be obtained using a
proteomic approach, which to the best of our knowledge
has not been presented thus far. The vastus lateralis
muscle however, has been the subject of a number of
proteomic studies [17-22] comparing different muscle
groups [19,23,24], ageing versus young skeletal muscle
[20], effects of high altitude [17,18,21] or interval exer-
cise training [22].
In the present study, 2-dimensional difference gel elec-
trophoresis (2D-DIGE) [25] was performed for compari-
son between the trapezius and vastus lateralis muscles.
2D-DIGE enables a simultaneous quantitative and
unbiased analysis of a large number of proteins
[19,23,24]. The integration of a pooled internal standard
[26] enables a standardization of all gels included in the
analysis, lowering the gel to gel differences in the data
analysis, which is the main technical variation in human
skeletal muscle proteomics [27]. A recent paper by
Cairns et al 2009 [28] addressing sample size and tech-
nical and biological variation, states the significance of
performing in house tests on protocol and sample size.
The protocol used in the present study has been vali-
dated and tested for repeatability [27].
The vast number of protein spots detected in the 2D-
DIGE analysis is evaluated statistically for their signifi-
cant higher abundance in either muscle. Different statis-
tical approaches can be used on this type of large
proteomic data sets, where as the most commonly used
statistical method is one-way analysis of variance
(ANOVA) (p < 0.05) on individual protein spots. To
avoid false positives (type-1 error) due to multiple test-
ing a correction for number of conducted tests should
be made. Considered as best practice, false discovery
rate (FDR) correlation [29] is applied when approaching
proteomic data [30]. In addition, the use of multivariate
statistical analysis has the advantage of extracting addi-
tional information from the vast data set [31]. In the
present study we applied one-way ANOVA statistics
with and without FDR correlation and multivariate
modelling by partial least square projection to latent
structures with discriminant analysis (PLS-DA).
T oo u rk n o w l e d g e ,n op r e v i o u ss t u d yh a su s e dt h i s
explorative approach to elucidate the proteome of the
human trapezius muscle. This study compares the phy-
siological characteristics of two muscles with different
structure and function, the trapezius and vastus lateralis.
A large number of protein spots are detected and ana-
lysed for significance with one-way ANOVA. Correla-
tion for false positives (FDR) is applied and compared
with results without FDR correlation. In addition, multi-
variate modelling is preformed in order to visualize and
compare the results obtained from the different statisti-
cal approaches. The proteins identified are spots that
differ significantly in abundance between the trapezius
and the vastus lateralis muscles according to the FDR
correlated one-way ANOVA. The detected proteins are
contractile, metabolic and regulatory. Results will serve
as a basis for future investigations of the proteomic
traits of the trapezius muscle in disease.
Methods
Samples
Samples (5-11 mg) were obtained by surgical biopsy
from the vastus lateralis muscle and from the descend-
ing portion of the trapezius muscle from five healthy
male voluntary donors, 25-28 years old. Both biopsies,
from the same donor, were taken at the same occasion
and by a single surgeon. All subjects gave their informed
consent and the study was approved by the regional
ethical committee. The muscle samples were rapidly
mounted in Tissue-Tek medium (Miles Laboratories,
IN, USA), and frozen in isopropanol chilled in liquid
nitrogen and stored at -70°C. Muscle tissue to be used
for 2D-DIGE was thoroughly cleared from Tissue-Tek
before homogenization.
Two-Dimensional Difference Gel Electrophoresis (2D-DIGE)
The 2D-DIGE method was primarily presented by Alban
et al [32] and further developed with the internal stan-
dard method by Unlü et al. [25]. The protocol used
herein on human skeletal muscle is validated and tested
for its repeatability in our lab [27]. Unless otherwise sta-
ted, all chemicals were from GE Healthcare, Uppsala,
Sweden, and of proteomic grade quality. The frozen
muscle samples were suspended in lysis buffer (9.5 M
Urea, 4% (v/w) CHAPS and 30 mM Tris Base) and
homogenized using a Grinding Kit. The protein content
was quantified with a 2D-Quant Kit. A protein yield of
approximately 20% of the total biopsy weight was
obtained (approximately 1-2.2 mg protein). Protein
homogenate samples, containing 50 μgo fp r o t e i n ,w e r e
labelled with CyDye minimal dyes, Cy2, Cy3 and Cy5,
according to manufacturers’ protocol. The internal stan-
dard method was used [33] incorporating a pooled
internal standard labelled with Cy2. In order to reduce
variation in the data-set due to difference in characteris-
tics of the different fluorescent dyes, a dye swap was
conducted when labelling all the samples. Trapezius and
vastus lateralis samples from a single donor were
labelled with Cy3 and Cy5, respectively. In samples from
the next donor the labelling was reversed, i.e. trapezius
labelled with Cy5 and vastus lateralis with Cy3. The
samples from one donor, labelled with one of each dye,
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equal volume of lysis buffer was added to all labelled
protein samples. The analytical gels were analysed in a
single replicate approach. IPG-buffer pH 3-11 was
added to the homogenates to a final concentration of
0.6% (w/v). DeSteak™ rehydration solution was added
to a final volume of 450 μl. The samples were applied
onto 24 cm 3-11 Non-Linear (NL) Immobilised pH gra-
dient (IPG) strips and rehydrated in the dark for 16
hours, at room temperature. The first dimension was
run using an Amersham Ettan™ IPGphor unit applying
300 V for 900 Vhrs, 600 V for 1800 Vhrs, 1000 V for
3000 Vhrs, 5000 V for 55000 Vhrs. Prior to the second
dimension each strip was equilibrated for 10 minutes in
equilibration buffer (50 mM 1.5 M Tris HCl pH 8.8, 6
M Urea, 30% (v/v) Glycerol (87%), 2% (w/v) SDS, trace
of Bromophenol blue and 0.5% DTT). Samples were
then alkylated by further equilibration for 10 minutes in
t h es a m eb u f f e r ,c o n t a i n i n g4.5% (w/v) iodoacetamide
instead of DTT. The second dimension was conducted
by loading the strips onto a 12.5% acrylamide gel using
the Ettan DALT six apparatus. Gels were run at 5 W
per gel, for 30 minutes, followed by additional 5 hours
or until the blue front reached the bottom of the gel,
with 17 W per gel of a constant temperature of 15°C
and in the dark. Gels were then immediately scanned
with a Typhoon™ 9410 scanner, using 488 nm laser
and emission filter of 520 BP40 for Cy2 labelled pro-
teins, 532 nm laser and emission filter 580 nm BP30 for
Cy3 and 633 nm laser and 670 nm BP30 for Cy5. The
image was processed using ImageQuant™ V5.2, before
protein abundance was determined using DeCyder™
V6.5.
Statistical analysis
Statistical evaluation of the protein abundance in the
2D-DIGE analysis was made using the Biological Varia-
tion Analysis (BVA) module in DeCyder™ V6.5 and
multivariate modelling was performed using SIMCA-P
12 (Umetrics AB, Umeå, Sweden). In all statistical ana-
lyses, the log of the standardized abundance has been
used. The standardized log abundance was derived from
the ratio of each pooled protein group (each gel) being
normalized by the internal standard. In the Differential
In-gel Analysis (DIA) either all 2447 protein spots or
663 protein spots, when applying the exclude filter with
the spot volume limit was set to 200 000 a.u. were
included in the BVA. Spots with slope values < 1.0 were
considered non-protein spots and not included in the
analysis. Differences between proteins were assumed to
be significant if spots were present in all gels and one-
way ANOVA were significant (p < 0.05) between
groups. FDR correlations [29] were applied according to
the DeCyder manual. No spot volume limit was set to
spots included in the multivariate modelling and all
spots were required to be present in all gels. In the mul-
tivariate analysis (PCA and PLS-DA) the spot volume
ratios were mean centred and scaled for unified var-
iance. PCA was used to detect outliers among the obser-
vations (i.e technical problems with gels). In the PLS-
DA, protein spots with regression coefficients for which
the jack-knifed 95% confidence interval did not included
0 and the Variable of importance (VIP) value exceeded
1 were considered of importance. PLS-regression coeffi-
cients have recently been shown to be applicable in
selection of variables in -omnic data sets when using
PLS-DA [34]. Previously, the combination of VIP-values
and PLS-regression coefficients provided the most reli-
able estimation of relevant variables [35]. In the Western
blot analysis, differences in relative protein content
between the trapezius and vastus lateralis muscle was
considered significant if p < 0.05 using an unpaired stu-
dents t-test.
Protein identification by MALDI-TOF mass spectrometry
All significant and FDR-correlated protein spots were
selected for further identification with matrix assisted
laser desorption ionisation time of flight (MALDI-TOF)
mass spectrometry. Protein spots identified as interest-
ing in the non-FDR correlated one-way ANOVA and
the PLS-DA modelling were not all identified with
MALDI-TOF-MS, due to low protein content in the gel
spot and a further insufficient access of biopsy material.
Gels to be used for protein identification were run as
above and used for both manual and automated exci-
sion. Protein spots were excised using Ettan™ Spot
Handling Workstation (GE Healthcare), with a ∅ 2.0
mm picker head, at the Swegene Proteomics Resource
Centre in Lund, Sweden. Gels to be manually excised
were loaded with 450 μg unlabelled protein and stained
with Coomassie brilliant blue 450 after 2D separation.
Mass spectrometry procedures have been described pre-
viously [36]. Database searches were carried out using a
M a s c o ts e r v e rl i c e n s e dt oU m e åU n i v e r s i t yb yM a t r i x
science http://www.matrixscience.com using Swiss-Prot
and IPI-human databases. The databases were searched
using peptide mass fingerprint spectra and post-source
decay MS/MS spectra.
Morphological analysis
Serial cryostat sections, 8 μm thick, were air-dried and
then rehydrated in 0.01 M PBS, immersed in 5% non-
immune serum and incubated with primary antibodies
for 60 min at 37°C or overnight at 4°C. Biopsy sections
were dyed with antibodies at several occasions, at least
triplicates were made to verify accuracy. Myotilin was
detected with a rabbit polyclonal antibody raised against
recombinant N-terminal fragment (residues 1-151) [37],
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oxireductase 30 kDa subunit (NDUSF antibody 17D95)
[39] were identified with mouse monoclonal antibody.
The mouse monoclonal antibody A4951 against slow
myosin heavy chain was used to easily identify the type
1 fibers, and the monoclonal antibody A474 against fast
myosin heavy chain, both antibodies were from Devel-
opmental Studies Hybridoma Bank maintained by the
University of Iowa, Department of Biology, Iowa city,
IA, USA. Visualization of bound antibodies was per-
formed with indirect fluorescence using Alexa 488 and
Alexa 568 (Molecular Probes Inc., Eugene, OR, USA).
The sections were evaluated in a Nikon eclipse E 800
microscope (Nikon Inc., Melville, NY, USA) and a
SPOT RT Color camera (Diagnostic Instruments Inc.,
Sterling Heights, MI, USA) was used for image acquisi-
tion. Digital images were processed using the Adobe
Photoshop software (Adobe Systems Inc., Mountain
V i e w ,C A ,U S A ) .T h es a m es e to ft r a p e z i u sb i o p s i e s
used in this study have previously been characterized
microscopically and contain 64 ± 6% type 1 fibers, 26 ±
10% type 2A fibers and 9.5 ± 8% type 2AB fibers [40].
Western blot analysis
Equal amounts of protein from pooled samples of either
trapezius or vastus lateralis muscles were loaded on pre-
cast 10% SDS-page gels (CBS-scientific, Del Mar, CA,
USA) and separated by electrophoresis (DCX-700, CBS-
scientific, Del Mar, CA, USA) (running buffer: 25 mM
Tris, 250 mM Glycine, 0,1%SDS). The proteins were
blotted (transfer buffer: 25 mM Tris, 250 mM Glycine,
20% methanol) on a PVDF membrane (Thermo Fisher
Scientific, Waltham, MA, USA) using Bio Rad semi-dry
blotting system (Bio Rad Laboratories Ltd, Cambridge,
UK). Unspecific binding was blocked by 5% w/v nonfat
dry milk in TBST (TBS with 0,1% Tween-20) at 4°C
over night. The membrane was incubated for 1 hour in
RT with primary antibodies (anti-beta-enolase, GeneTex,
GTX 113429S, polyclonal rabbit; at concentration
1:1000, anti-phosphoglycerate mutase 2, GeneTex,
GTX109582S, polyclonal rabbit; at concentration 1:1000
and anti-alpha-crystalline beta, Novacastra, NCL-
ABCrys-512, monoclonal mouse, at 1:200 concentration)
in 5% w/v nonfat dry milk in TBST. The membrane was
washed and incubated with either secondary anti-rabbit
or anti-mouse alkaline-phosphate-conjugated antibodies
in 5% w/v nonfat dry milk in TBST for 1 hour in RT
(anti-rabbit/AP, DakoCytomation, D 0487, polyclonal
goat at concentration 1:1000 or anti-mouse, GenTex,
GTX 27062, polyclonal donkey; at concentration
1:1000). The blots were developed by incubating the
membrane with BCIP/NBT (Thermo Fisher Scientific
Waltham, MA, USA) until desired staining was
achieved. The membranes were photographed and
analyzed using ChemiDoc XRS (Bio Rad Laboratories
Ltd, Cambridge, UK) with Quantity One software ver-
sion 4.6.6 (Bio Rad Laboratories Ltd, Cambridge, UK).
The relative protein content was calculated based on the
detection of pixel volumes of the photographed mem-
branes. Background pixel volume was subtracted from
each protein band. All western blot analysis was con-
ducted in, at least, triplicates to verify accuracy.
Results
A total of 2447 protein spots were detected in the 2D-
DIGE gel from vastus lateralis and trapezius muscle
extracts. Without applying any spot volume limit in the
DIA module, a statistical analysis was made in the
DeCyder V6.5 BVA module. Of the 2447 protein spots,
545 spots were present in all gels. No protein spots
were exclusive for either muscle. When applying the
one-way ANOVA, 140 spots were present in signifi-
cantly different amounts (p < 0.05) and present in each
and every gel (Figure 1A). Forty-two of the 140 protein
spots were significant when applying the false discovery
rate (FDR) correlation (Figure 1B).
Out of 42 significant protein spots 14 different pro-
teins were identified using MALDI-TOF mass spectro-
metry (Figure 2). The proteins detected related to
oxidative metabolism, NADH ubiquinone oxidoreduc-
tase 30 kDa subunit (O75489), carbonic anhydrase 1
(P00915) and carbonic anhydrase 3 (P07451), were all
more abundant in the trapezius muscle. ATP synthase
beta chain (P06576), also related to oxidative metabo-
lism, was more abundant in vastus lateralis compared to
trapezius. Creatine kinase M-type (P06732), an enzyme
important in anaerobic metabolism, as well as beta eno-
lase (P13929), an enzyme active in glycolysis; were more
abundant in the vastus lateralis. Fast myosin light chains
(P06741, Q96A32) were significantly more abundant in
vastus lateralis whereas slow myosin light chains
(P10916, P14649) were more abundant in trapezius.
Myotilin (Q9UBF9), smooth muscle actin (P62736) and
alpha crystalline beta chain (P02511) were more abun-
dant in the trapezius muscle. Proteins significant at p <
0.01 were NADH ubiquinone oxidoreductase, carbonic
anhydrase 1 and 3, alpha crystalline beta, MyLC1A alkali
slow and actin aortic smooth muscle (table 1).
When setting the protein spot volume limit in the
exclusion filter of the DIA module to 200.000 a.u., a
total of 663 spots were included in the BVA one-way
ANOVA, as compared to 2447 protein spots when no
exclusion filter was applied, with 96 protein spots signif-
icantly different, and when applying the FDR correlation
the number diminished to 26 (Figure 1D). Some protein
spots considered statistically significant in the FDR cor-
related one-way ANOVA when including all 2447 spots
(presented in table 1), did not appear as significant
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using the 200.000 a.u. DIA filter settings, and vice versa,
visualised in Figure 1B and 1D. This is due to the spot
volume normalization algorithm in DeCyder.
Proteins considered not significant when setting the
DIA exclusion filter spot volume limit to 200.000 a.u.
where ATP synthase beta chain (P06576), smooth mus-
cle actin (P62736), fast myosin light chain 3 alkali
(P06741), myotilin (Q9UBF9) and creatine kinase M-
type (P06732). Interestingly, the glycolytic enzyme,
phosphoglycerate mutase 2 (P15259) (Figure 1D andta-
ble 1) was not significant in the analysis where all 2447
spots were included. However, it is significant in the
analysis where the exclusion filter was applied according
to the FDR correlated one-way ANOVA. In the non-
FDR correlated one-way ANOVA, where no exclusion
filter was applied and all spots are included (presented
in Figure 1C), phosphoglycerate mutase 2 was consid-
ered significant. When performing a western blot analy-
sis on phosphoglycerate mutase 2, a higher abundance
(1.21 fold increased abundance, p < 0.05 students- t-
test) in the trapezius muscle was confirmed (Figure 3).
All protein spots, present in 5 out of 5 gels (545 spots)
were modelled using PCA and no outliers were found
among gels (data not shown). In the PLS-DA analysis
(Q
2
cum = 0.81 for 2 PLS-components, 27% and 19%
explained variance on component 1 and 2, respectively)
164 protein spots (Figure 1C) had a variable of impor-
tance (VIP) value higher than 1 and a regression coeffi-
cient for which the jack-knifed 95% confidence interval
did not included 0 (Figure 4). Spots significant in the
above mentioned one-way ANOVA analysis, both with
Figure 1 Protein spots of interest using different statistical and pre-processing techniques. Trapezius muscle homogenate on 12.5%
preparative gel scanned with Typhoon scanner™. pH range 3-11 and molecular weight 15-150 kDa. 1A: Proteins spots significant according to
the one-way ANOVA analysis, not FDR correlated. 1B: Protein spots significant according to the one way ANOVA and FDR correlated. 1C: Protein
spots of interest in the PLS-DA model: VIP-values higher than 1 and a regression coefficient with a jack-knifed 95% confidence interval not
including 0. 1D: Proteins spots significant according to one-way ANOVA and FDR correlated, when a spot volume exclude filter of 200 000 au is
applied. Arrows indicate spots identified as phosphoglycerate mutase 2 (P15259).
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DA weights plot (Figure 4), to illustrate the overlap
between PLS-DA and one-way ANOVA.
Validation of differentially expressed proteins
In order to verify the results from the 2D-DIGE, beta
enolase (1,67 fold change) alpha crystalline beta chain
(2,0 fold change) and phosphoglycerate mutase 2 (1.74
fold change) were selected for western blot analysis and
alpha crystalline beta, myotilin and NADH ubiquinone
oxireductase were selected for immunohistochemistry.
The expression of beta enolase was shown in western
blots to be higher in vastus lateralis (1.86 fold change, p
< 0.05 students t-test), and alpha crystalline beta chain
to be higher in trapezius (2.09 fold change, p < 0.05 stu-
dents t-test) (Figure 3). The results are in agreement
with the proteomics analysis (table 1).
Immunohistochemistry was performed on tissue sec-
tions from both the trapezius and the vastus lateralis
muscles. Using immunohistochemistry, the exact
Table 1 Identified proteins
Swiss prot ID/
Protein
identifier
Protein name/
description
p-value
(ANOVA)
Ratio
V/T
Protein
mass
[Da]
Mascot
score
Matched/
detected
peptides
Sequence
coverage
O75489 NADH ubiquinone
oxidoreductase
0.00058 -10.39 30242 63 6 33
P00915 Carbonic anhydrase 1 0.0064 -2.21 28778 126 17 60
P02511 Alpha crystalline b 0.0026 -2.09 20146 177 16 69
P06576 ATPsynthase B 0,023 1.57 56525 227 30 58
P06576 ATPsynthase B 0.030 1.52 56525 143 31 50
P06732 Creatine Kinase M-type 0,025 1.35 43302 194 21 55
P06741 MyLC 3 fast alkali 0,030 2.51 16599 143 12 61
P07451 Carbonic anhydrase 3 0.00071 -2.45 29707 81 9 27
P07451 Carbonic anhydrase 3 0.0020 -2.15 29707 146 13 43
P07451 Carbonic anhydrase 3 0.0041 -1.99 29707 162 15 56
P07451 Carbonic anhydrase 3 0.021 -1.83 29707 147 17 72
P10916 MyLC 2, slow regulatory/
ventricular
0.015 -2.15 18646 133 14 70
P13929 Beta enolase 0,025 1.69 47168 216 21 58
P14649 MyLC1A alkali slow 0.00058 -10.73 22864 163 7 26
P14649 MyLC1A alkali slow 0.00071 -8.69 22864 71 4 21
P62736 Actin aortic smooth muscle 0.0080 -1.88 42381 70 13 34
P62736 Actin aortic smooth muscle 0.025 -1.80 42381 71 8 22
P69905 Hemoglobulin alpha 0.046 -2.13 15174 63 6 48
Q96A32 MyLC 2 fast regulatory 0.023 1.77 19188 93 13 50
Q9UBF9 Myotilin 0,031 -2.56 55760 169 19 50
Q9UBF9 Myotilin 0,032 -2.17 55760 176 17 41
P15259 Phosphoglycerate
mutase 2
0.071 -1.6 28788 126 19 64
Identified proteins significantly different between trapezius and vastus lateralis using FDR correlated one-way ANOVA; and phosphoglycerate mutase 2 (P15259):
significantly different only when applying a spot volume exclude filter of 200 000 au. Mascot score values are significant (p < 0.05) when greater than 54.
Figure 2 Preparative 2D-gel with accession numbers for
identified proteins. Typhoon scanner™ image. Cy2 dyed sample
from the trapezius muscle within the pH range 3-11 and molecular
weight 15-150 kDa. Accession numbers for identified proteins are
indicated and listed in Table 1.
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sections treated with antibodies against slow and fast
myosin heavy chains revealed type 1 and type 2 muscle
fibers in a typical salt and pepper pattern (Figure 5).
Specific antibodies against alpha crystalline beta, myoti-
lin and NADH ubiquinone oxireductase (Figure 5),
representing structural and metabolic proteins, showed
higher immunoreactivity in the trapezius muscle, corre-
lating to the predominance of type 1 fibers and thus
likely reflecting a relative difference in protein amounts
between type 1 and type 2 fibers. Although immunohis-
tochemistry is not a quantitative method, differences in
staining intensity within the same tissue section reflect
relative differences in protein content.
Discussion
The protein spots detected to differ significantly in
abundance between the trapezius and the vastus lateralis
muscles are contractile, metabolic and regulatory pro-
teins that reflect the distinct structural and functional
properties of the trapezius muscle. Also, a combination
of different statistical methods was applied to obtain a
more comprehensive evaluation of the data.
Major protein findings
The detected differences in content of significant and
FDR correlated contractile proteins (e.g. myosin light
chains) and metabolic proteins (carbonic anhydrase,
NADH ubiquinone oxireductase) are related to fiber
Figure 3 Western blot results. Western blots analysis on equal amounts of pooled homogenate from trapezius (T) muscle and vastus lateralis
(V) muscle using specific antibodies for: A, beta enolase, B, alpha crystalline beta and C, phosphoglycerate mutase 2. Graphs show mean pixel
volumes (intensity *mm2) and error bars show the standard deviation (n = 3). * p < 0.05 (students t-test).
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analysis showed a clear difference in MyLC composition
between trapezius and vastus lateralis muscles, with a
predominance of slow isoforms in the trapezius muscle
(table 1). MyLC2, slow regulatory (P10916) and MyLC1A
slow alkali (P14649) were more abundant in the trapezius
muscle, compared to the fast isoforms MyLC2 fast regu-
latory (Q96A32) and MyLC3 fast alkali (P06741) which
were more abundant in the vastus lateralis muscle. In
healthy adult human muscle the slow isoforms of the
alkali and regulatory light chains are expressed in slow
type 1 fibers only, whereas the fast alkali isoforms are
present in both type 1 slow twitch and type 2 fast twitch
fibers [41]. Previous studies have shown that the trape-
zius has a higher abundance of type 1 fibers compared to
vastus lateralis [40,42]. The results from our 2D-DIGE
analysis, showing a higher abundance of slow MyLC in
trapezius hence are in agreement with earlier results.
Structural proteins may have a more subtle relation to
fiber types. In the present study we found that myotilin
(Q9UBF9) was more abundant in trapezius compared to
vastus lateralis. Myotilin is present in the myofibrillar Z-
discs [43]. Type 1 fibers, which are more abundant in
trapezius than in vastus lateralis muscle [9,10,42], have
broader Z-discs [44] and the trapezius muscle may
therefore be expected to exhibit higher abundance of
myotilin (Figure 5).
Metabolic proteins also differed between trapezius and
vastus lateralis. NADH ubiquinone oxireductase 30 kDa
subunit (O75489), one of the subunits in complex 1 of
the mammalian mitochondrial electron transport chain
and the major superoxide producing component [45],
was more abundant in trapezius muscle (Figure 5). ATP
synthase beta chain (P06576) is the last complex in the
electron transport chain, using protons to build up elec-
tron gradient for the phosphorylation of ADP to ATP
[46]. It is hence expected that ATP synthase beta chain
would be more abundant in the trapezius muscle, in par-
ity with NADH ubiquinone oxireductase 30 kDa subunit,
because both proteins are involved in the electron trans-
port chain. Instead there was a higher abundance of ATP
synthase beta chain in the vastus lateralis Previous results
show a independence in activity between these proteins
as both have a suggested reverse action in both consum-
ing and producing protons in the electron transport
chain [44,47]. The suggested reverse action of NADH
ubiquinone oxidoreductase produces more harmful reac-
tive agents or free radicals, the superoxide anions [48,49],
in comparison to the regular activity of the protein.
A preceding proteomic study [19] comparing the vastus
lateralis to the deltoideus suggested that two proteins, per-
oxiredoxin and heat shock protein (HSP) 6b,w e r ea d e -
quate markers of fiber type composition and muscle
function, having a direct relationship to free radicals
Figure 4 Protein spot contribution to discrimination between vastus lateralis and trapezius. PLS-DA weight plot (w*c[1]/w*c[2]) based on
545 protein spots. Situated on the left in the figure are protein spots characterizing the vastus lateralis muscle and on the right the trapezius
muscle. Shaded area is proteins spots with variable of importance values (VIP) < 1. Protein spots significant according to the one way ANOVA
and FDR correlated (◆). Protein spots significant according to one way ANOVA but not FDR correlated (◆). Protein spots not significant (○). PLS-
DA model with two PLS-components ([t1],[t2]) represents 46% of the Y-variance ([t1], 27%, [t2] 19%).
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HSP6b were not identified among the differentially
expressed proteins of trapezius and vastus lateralis, as no
significant differences in protein abundance were observed
when applying the FDR correlated one-way ANOVA.
Statistical approaches
In our analysis we detected fourteen proteins involved in
contractile, metabolic and regulatory functions of the
muscle that differed significantly in abundance between
trapezius and vastus lateralis according to the FDR cor-
related one-way ANOVA (Figure 2, table 1).
This approach, using the one-way ANOVA with FDR
correlation is the most frequently used approach in pro-
teomic analysis and is considered to be the correct way
to approach proteomic data as it is integrated in the
BVA module of the DeCyder program. The FDR corre-
lation should, according to Benjamini and Yekuteli 2001
[ 5 0 ] ,p a r t i c u l a r l yb eu s e dw h e nt h e r ei sac o r r e l a t i o n
between variables. Protein spots appearing when using
proteomic methods are hence considered to be corre-
lated although proteins are the product of a number of
independent translations of genes.
Using multivariate modelling, a general overview of
the data is provided [31] proposing a proteomic finger-
print of the muscle. From this fingerprint, proteins with
biological relevance can be extracted and further exam-
ined with other methods and research approaches. The
spots that are significant when using one-way ANOVA
and FDR correlation could be considered proteins that
are significant as biomarkers, although the biological sig-
nificance of these proteins must be considered. To
obtain as much data as possible, a combination of differ-
ent univariate and multivariate statistical analysis meth-
ods (Figure 1 and 4) is needed in order to ensure that
as much information as possible is extracted from the
vast data set.
Methodological considerations
The fact that in the present study not more metabolic
enzymes differed significantly between the trapezius and
vastus lateralis samples (Figure 2) may be due to metho-
dological issues such as, for example, the choice of buf-
fer solutions, gel density [51] and low abundant proteins
not seen due to high abundant proteins. The 2D-DIGE
method only allows analysis within a limited pH (3-11)
and molecular weight range (15-150 kDa). In order to
make a more focused proteomic analysis of the meta-
bolic proteins only, a mitochondrial extraction would be
desirable [52]. Though, mitochondrial extractions has
limitations as other proteins may contaminate the analy-
sis due to defective purification [53] and hence change
the protein to protein relationship. Also, immunohisto-
chemical and immunoblotting approaches have inherent
limitations when considering epitope availability.
The present study has shown a number of proteins
that differ between trapezius and vastus lateralis muscle
thereby revealing the physiological properties of each
muscle. Depending on the choice of statistical method
and the pre-processing of the gel images, partially differ-
ent results and conclusions can be drawn from the 2D-
DIGE proteomic analysis. When using the stringent
FDR correlated one way ANOVA, potential biomarkers
for function, disease or structure might be discovered,
Figure 5 Serial sections of trapezius and vastus lateralis muscle
with fluorescence labelling. To illustrate the presence of slow and
fast muscle fibers, sections were stained with antibodies against
MyHCIIa (fast type 2a) (A and F) and MyHCI (slow type 1) (B and G).
Adjacent sections were further stained with antibodies against
Myotilin (C and H), NADH ubiquinone oxireductase (D and I) and
Alpha crystalline beta (E and J); (*type 1 fiber **type 2 fiber). Note
the predominance of type 1 fibers in the trapezius muscle and the
type 1 fibers higher reactivity to the myotilin, NADH ubiquinone
oxireductase and alpha crystalline beta antibodies.
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found is not considered. To reveal the biological signifi-
cance of each protein, thorough pathway analyses needs
to be performed in order to further elucidate the exact
function of each protein and its interaction with other
proteins. Careful consideration must be taken regarding
the choice of statistical method, depending on what to
study and why the analysis is made. As a screening
method, 2D-DIGE method is both reliable and sensitive
[27] and can reduce the number of proteins targeted for
further independent analysis.
Conclusions
The proteomic approach used in the present study com-
bining 2D-DIGE and PLS-DA as an explorative screen-
ing approach provided a comprehensive comparison of
the protein profiles of the human trapezius and vastus
lateralis muscles, showing significant differences in sar-
comeric proteins and proteins related to metabolism. By
using the “by the book method”, one way ANOVA with
FDR correlation, information obtained by the 2D-DIGE
method is limited as a number of proteins that may be
of interest when using 2D-DIGE is lost. To obtain as
much data as possible, a combination of different uni-
variate and multivariate statistical analysis methods is
recommended, in order to ensure that all relevant infor-
mation is extracted from the vast data set. The 2D-
DIGE method is particularly useful to comprehensively
detect important structural and metabolic proteins, and
it is a promising tool for future studies of patients suf-
fering from chronic work related myalgia in the trape-
zius muscle.
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